title: Effects of G-CSF on cardiac remodeling after acute myocardial infarction in swine.
abstract: We examined whether granulocyte colony-stimulating factor (G-CSF) prevents cardiac dysfunction and remodeling after myocardial infarction (MI) in large animals. MI was produced by ligation of left anterior descending coronary artery in swine. G-CSF (10 microg/kg/day, once a day) was injected subcutaneously from 24h after ligation for 7 days. Echocardiographic examination revealed that the G-CSF treatment induced improvement of cardiac function and attenuation of cardiac remodeling at 4 weeks after MI. In the ischemic region, the number of apoptotic endothelial cells was smaller and the number of vessels was larger in the G-CSF treatment group than in control group. Moreover, vascular endothelial growth factor was more abundantly expressed and Akt was more strongly activated in the ischemic region of the G-CSF treatment group than of control group. These findings suggest that G-CSF prevents cardiac dysfunction and remodeling after MI in large animals.
authors.affiliation: Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
authors.forename: Koji
authors.initials: K
authors.lastname: Iwanaga
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Takano
authors.forename: Masashi
authors.initials: M
authors.lastname: Ohtsuka
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Hasegawa
authors.forename: Yunzeng
authors.initials: Y
authors.lastname: Zou
authors.forename: Yingjie
authors.initials: Y
authors.lastname: Qin
authors.forename: Kenichi
authors.initials: K
authors.lastname: Odaka
authors.forename: Kenzo
authors.initials: K
authors.lastname: Hiroshima
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Tadokoro
authors.forename: Issei
authors.initials: I
authors.lastname: Komuro
mesh_terms: D000818:Animals; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D007279:Injections, Subcutaneous; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt; D013552:Swine; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism; D018487:Ventricular Dysfunction, Left / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology*; D020257:Ventricular Remodeling / Q000187:drug effects* / Q000502:physiology*
chemical_list: D011518:Proto-Oncogene Proteins; D042461:Vascular Endothelial Growth Factor A; D016179:Granulocyte Colony-Stimulating Factor; D017346:Protein Serine-Threonine Kinases; D051057:Proto-Oncogene Proteins c-akt